Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 28, 2011 - Issue 4
Submit an article Journal homepage
179
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEMalignant Hematology - Acute Myeloid Leukemia

Improved Survival Outcome of Childhood Acute Myeloid Leukemia with Intensified Chemotherapy in Chinese Children

Xiao Wen ZhaiDepartment of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong; and Department of Pediatrics, Children's Hospital of Fudan University, Shanghai, China
, PhD , MD,
Frankie Wai Tsoi ChengDepartment of Pediatrics, Prince of Wales Hospital, Shatin, New Territories, The Chinese University of Hong Kong, Hong Kong
, MD,
Vincent LeeDepartment of Pediatrics, Prince of Wales Hospital, Shatin, New Territories, The Chinese University of Hong Kong, Hong Kong
, MRCP,
Wing Kwan LeungDepartment of Pediatrics, Prince of Wales Hospital, Shatin, New Territories, The Chinese University of Hong Kong, Hong Kong
, MRCPCH,
Margaret Heung Ling NgDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
, MD,
Kam Sze TsangDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
, PhD,
Ming Kong ShingDepartment of Pediatrics, Prince of Wales Hospital, Shatin, New Territories, The Chinese University of Hong Kong, Hong Kong
, FRCP &
Chi Kong LiDepartment of Pediatrics, Prince of Wales Hospital, Shatin, New Territories, The Chinese University of Hong Kong, Hong KongCorrespondence[email protected]
, MD show all
Pages 269-278 | Received 02 Jun 2010, Accepted 15 Oct 2010, Published online: 23 Feb 2011

REFERENCES

  • Pui CH. Childhood leukemia. N Engl J Med. 1995;332:1618–1627.
  • Gibson BE, Wheatley K, Hann IM, Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia. 2005;19:2130–2138.
  • Lie SO, Abrahamsson J, Clausen N, Long-term results in children with AML: NOPHO-AML Study Group—report of three consecutive trials. Leukemia. 2005;19:2090–2100.
  • Creutzig U, Zimmermann M, Ritter J, Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005;19:2030–2042.
  • Ravindranath Y, Chang M, Steuber CP, Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia. 2005;19:2101–2116.
  • Li CK, Leung NK, Wong HW, Acute non-lymphoblastic leukemia-local experience. Hong Kong J Pediatrics. 1991;8:31–37.
  • Hasle H, Niemeyer CM, Chessells JM, A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17:277–282.
  • Stevens RF, Hann IM, Wheatley K, Marked improvements in outcome with chemotherapy alone in pediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. Br J Haemotol. 1998;101:130–140.
  • Rubnitz JE. Childhood acute myeloid leukemia. Curr Opin Oncol. 2008;9:95–105.
  • Creutzig U, Reinhardt D. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? A European view. Br J Haematol. 2002;118:365–377.
  • Chen AR, Alonzo TA, Woods WG, Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?—an American view. Br J Haematol. 2002;118:378–384.
  • Smith FO, Alonzo TA, Gerbing RB, Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia. 2005;19:2054–2062.
  • Aladjidi N, Auvrignon A, Leblanc T, Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol. 2003;21:4377–4385.
  • Wells RJ, Adams MT, Alonzo TA, Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. J Clin Oncol. 2003;21:2940–2947.
  • Rubnitz JE, Razzouk BI, Lensing S, Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer. 2007;109:157–163.
  • Nemecek ER, Gooley TA, Woolfrey AE, Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant. 2004;34:799–806.
  • Aladjidi N, Auvrignon A, Leblanc T, Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol. 2003;21:4377–4385.
  • Woolfrey AE, Gooley TA, Sievers EL, Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood. 1998;92:3546–3556.
  • Grimwade D, Walker H, Oliver F, The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92:2322–2333.
  • Raimondi SC, Chang MN, Ravindranath Y, Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study—POG 8821. Blood. 1999;94:3707–3716.
  • Balgobind BV, Raimondi SC, Harbott J, Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood. 2009;114:2489–2496.
  • Rubnitz JE, Lensing S, Razzouk BI, Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience. Pediatr Blood Cancer. 2007;48:10–15.
  • Li J, Gu LJ, Xue HL, Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia. Zhonghau Xue Ye Xue Za Zhi. 2004;25:351–354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.